News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
302,851 Results
Type
Article (16098)
Company Profile (107)
Press Release (286646)
Multimedia
Podcasts (47)
Webinars (10)
Section
Business (96207)
Career Advice (509)
Deals (16658)
Drug Delivery (71)
Drug Development (41596)
Employer Resources (51)
FDA (7693)
Job Trends (6865)
News (166343)
Policy (15624)
Tag
Academia (666)
Accelerated approval (2)
Adcomms (8)
Allergies (40)
Alliances (25076)
ALS (45)
Alzheimer's disease (472)
Antibody-drug conjugate (ADC) (57)
Approvals (7739)
Artificial intelligence (128)
Autoimmune disease (9)
Automation (5)
Bankruptcy (154)
Best Places to Work (5025)
BIOSECURE Act (9)
Biosimilars (64)
Biotechnology (44)
Bladder cancer (26)
Brain cancer (18)
Breast cancer (157)
Cancer (928)
Cardiovascular disease (98)
Career advice (445)
Career pathing (12)
CAR-T (34)
Cell therapy (119)
Cervical cancer (8)
Clinical research (35220)
Collaboration (391)
Compensation (175)
Complete response letters (19)
COVID-19 (840)
CRISPR (25)
C-suite (150)
Cystic fibrosis (46)
Data (971)
Denatured (15)
Depression (11)
Diabetes (140)
Diagnostics (1729)
Digital health (1)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (66)
Drug pricing (70)
Drug shortages (13)
Duchenne muscular dystrophy (45)
Earnings (36126)
Editorial (17)
Employer branding (5)
Employer resources (44)
Events (43335)
Executive appointments (436)
FDA (8302)
Friedreich's ataxia (2)
Frontotemporal dementia (2)
Funding (271)
Gene editing (46)
Generative AI (9)
Gene therapy (129)
GLP-1 (406)
Government (1488)
Grass and pollen (4)
Guidances (73)
Healthcare (4918)
Huntington's disease (5)
IgA nephropathy (21)
Immunology and inflammation (47)
Indications (20)
Infectious disease (882)
Inflammatory bowel disease (82)
Inflation Reduction Act (6)
Influenza (15)
Intellectual property (49)
Interviews (64)
IPO (6471)
IRA (30)
Job creations (2115)
Job search strategy (405)
Kidney cancer (7)
Labor market (14)
Layoffs (205)
Leadership (4)
Legal (3774)
Liver cancer (29)
Lung cancer (128)
Lymphoma (65)
Machine learning (4)
Management (17)
Manufacturing (179)
MASH (45)
Medical device (2910)
Medtech (2913)
Mergers & acquisitions (10426)
Metabolic disorders (367)
Multiple sclerosis (24)
NASH (14)
Neurodegenerative disease (28)
Neuropsychiatric disorders (9)
Neuroscience (687)
NextGen: Class of 2025 (1925)
Non-profit (909)
Now hiring (9)
Obesity (183)
Opinion (125)
Ovarian cancer (50)
Pain (62)
Pancreatic cancer (21)
Parkinson's disease (52)
Partnered (8)
Patents (141)
Patient recruitment (38)
Peanut (10)
People (31228)
Pharmaceutical (64)
Pharmacy benefit managers (12)
Phase I (9364)
Phase II (15102)
Phase III (13077)
Pipeline (647)
Policy (75)
Postmarket research (1516)
Preclinical (3837)
Press Release (27)
Prostate cancer (55)
Psychedelics (9)
Radiopharmaceuticals (133)
Rare diseases (193)
Real estate (2811)
Recruiting (18)
Regulatory (11348)
Reports (14)
Research institute (757)
Resumes & cover letters (63)
Rett syndrome (1)
RNA editing (2)
RSV (10)
Schizophrenia (41)
Series A (46)
Series B (22)
Service/supplier (4)
Sickle cell disease (36)
Special edition (6)
Spinal muscular atrophy (78)
Sponsored (7)
Startups (1782)
State (2)
Stomach cancer (5)
Supply chain (37)
Tariffs (38)
The Weekly (30)
Vaccines (181)
Venture capitalists (14)
Weight loss (121)
Women's health (15)
Worklife (4)
Date
Last 7 days (418)
Last 30 days (1236)
Last 365 days (13852)
2025 (5096)
2024 (14863)
2023 (16850)
2022 (22651)
2021 (23231)
2020 (21950)
2019 (17648)
2018 (13788)
2017 (15778)
2016 (14831)
2015 (17469)
2014 (13906)
2013 (11682)
2012 (12668)
2011 (13223)
2010 (12142)
Location
Africa (326)
Alabama (13)
Alaska (2)
Arizona (71)
Arkansas (4)
Asia (22078)
Australia (3005)
California (2336)
Canada (1066)
China (294)
Colorado (80)
Connecticut (102)
Delaware (82)
Europe (44084)
Florida (411)
Georgia (84)
Idaho (13)
Illinois (233)
India (18)
Indiana (151)
Iowa (1)
Japan (113)
Kansas (63)
Kentucky (14)
Louisiana (2)
Maine (2)
Maryland (331)
Massachusetts (1911)
Michigan (46)
Minnesota (129)
Missouri (47)
Montana (8)
Nebraska (7)
Nevada (16)
New Hampshire (10)
New Jersey (938)
New Mexico (9)
New York (670)
North Carolina (443)
North Dakota (4)
Northern California (972)
Ohio (64)
Oklahoma (5)
Oregon (19)
Pennsylvania (555)
Puerto Rico (9)
Rhode Island (12)
South America (542)
South Carolina (3)
Southern California (961)
Tennessee (38)
Texas (309)
United States (9334)
Utah (61)
Virginia (88)
Washington D.C. (32)
Washington State (161)
West Virginia (1)
Wisconsin (22)
302,851 Results for "endo pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Troubled Drugmakers Mallinckrodt, Endo Officially Announce $6.7B Merger
Both Mallinckrodt and Endo have previously declared bankruptcy, linked to opioid-related lawsuits.
March 13, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Endo Announces Divestiture of International Pharmaceuticals Business
March 11, 2025
·
4 min read
Press Releases
Mallinckrodt and Endo to Combine to Create a Global, Scaled, Diversified Pharmaceuticals Leader
March 13, 2025
·
28 min read
Press Releases
Endo Reports First-Quarter 2025 Financial Results and Reaffirms 2025 Financial Guidance
May 7, 2025
·
30 min read
Press Releases
Endo to Report First Quarter 2025 Financial Results on May 7, 2025
April 7, 2025
·
1 min read
Press Releases
Endo’s New Spatial Computing Injection Simulator for Peyronie’s Disease Creates Immersive Learning Environment for Urology Specialists
April 24, 2025
·
10 min read
Pharm Country
Endo Announces Commencement of OTCQX Trading
Endo, Inc. announced that the Company has commenced trading on the OTCQX® Best Market under the ticker symbol NDOI.
June 28, 2024
·
3 min read
Press Releases
Endo Reschedules Release of Fourth Quarter and Full Year 2024 Earnings Results and Conference Call
March 11, 2025
·
1 min read
Press Releases
Endo Announces Peyronie’s Disease Presentation at the Annual Meeting of the Southeastern Section of the American Urological Association
March 12, 2025
·
9 min read
Biotech Beach
Crinetics Pharmaceuticals to Present Advancements from Atumelnant (CRN04894) and Paltusotine Development Programs at ENDO 2024
Crinetics Pharmaceuticals, Inc. announced five abstracts from its clinical development programs, including four late-breaking abstracts, will be presented at the Endocrine Society’s annual meeting, ENDO 2024, taking place June 1-4, 2024 in Boston, Massachusetts.
May 8, 2024
·
8 min read
1 of 30,286
Next
